130 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
10
Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir.
Sankyo
19
Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir.
Sankyo
12
Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
Sankyo
20
Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.
National Tsing Hua University
5
A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.
Thammasat University
12
Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors.
National Taiwan University
21
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors.
Academia Sinica
10
Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
Central South University
7
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
Freie Universitaet Berlin
16
Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
TBA
9
Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome.
Chungnam National University
37
Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Shandong University
5
Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
Chinese Academy of Sciences
12
Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
University of Alberta
7
Development of oseltamivir phosphonate congeners as anti-influenza agents.
The Genomics Research Center
1
Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.
University of Alabama At Birmingham
3
Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.
Miyagi Cancer Center Research Institute
15
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.
National Taiwan University
4
Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
National Taiwan University
29
Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
Abbott Laboratories
7
BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Biocryst Pharmaceuticals
15
Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method.
University of Southampton
9
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Glaxo Wellcome Research and Development
3
Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis.
Monash University
17
Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.
Glaxowellcome Medicines Research Centre
11
Novel inhibitors of influenza sialidases related to zanamivir. Heterocyclic replacements of the glycerol sidechain
TBA
26
Novel inhibitors of influenza sialidases related to GG167 structure-activity, crystallographic and Molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides
TBA
8
Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase
TBA
9
Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases.
Korea Research Institute of Bioscience and Biotechnology
3
Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
Saitama University
4
The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
University of Victoria
35
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Peking Union Medical College
6
Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
Korea Research Institute of Bioscience and Biotechnology
2
Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.
St. Jude Children'S Research Hospital
6
Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai.
University of Innsbruck
8
Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.
Saitama University
40
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles.
Shandong University
15
Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
Shanghai Institute of Technology
47
Indole-core inhibitors of influenza a neuraminidase: iterative medicinal chemistry and molecular modeling.
Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences (Research Centre of Biotechnology RAS)
7
Natural products as potential lead compounds to develop new antiviral drugs over the past decade.
Nanjing University of Chinese Medicine
18
Discovery of novel polyheterocyclic neuraminidase inhibitors with 1,3,4-oxadiazole thioetheramide as core backbone.
Shanghai Institute of Technology
4
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.
Shandong University
42
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties.
Shandong University
3
The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A：A review.
Shenyang Pharmaceutical University
19
Conformationally locked sugar derivatives and analogues as potential neuraminidase inhibitors.
Jawaharlal Nehru University
5
Pterocarpan scaffold: A natural lead molecule with diverse pharmacological properties.
Texas Southern University
1
Natural and nature-inspired stilbenoids as antiviral agents.
Universita Degli Studi di Milano
53
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors
Shandong University
2
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.
Glaxosmithkline
3
Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.
Abbott Laboratories
25
Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
Shenyang Pharmaceutical University
20
Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.
Abbott Laboratories
11
Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
Prin. K.M. Kundnani College of Pharmacy
18
Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity.
National Taiwan University
34
Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
Shandong University
11
Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
University of Alabama At Birmingham
4
Total synthesis of dryocrassin ABBA and its analogues with potential inhibitory activity against drug-resistant neuraminidases.
Chinese Academy of Sciences
22
Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
Shandong University
3
Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
The Hong Kong Polytechnic University
8
Discovery of novel acylhydrazone neuraminidase inhibitors.
Shanghai Institute of Technology
22
Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1.
Charles University
1
Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay.
Shanghai Institute of Technology
3
Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
Wuyi University
2
1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
Universidade Federal Fluminense
6
Anti-influenza activities of polyphenols from the medicinal mushroom Phellinus baumii.
Chonbuk National University
3
Flavonoids from Matteuccia struthiopteris and Their Anti-influenza Virus (H1N1) Activity.
Shenyang Pharmaceutical University
14
Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery.
Griffith University
35
Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors.
Wuhan University School of Pharmaceutical Sciences
5
Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
Utrecht University
14
Computer-guided approach to access the anti-influenza activity of licorice constituents.
University of Innsbruck
4
Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
Christian-Albrechts University of Kiel
25
Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors.
Shandong University
26
Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors.
Shandong University
2
Aspulvinones from a mangrove rhizosphere soil-derived fungus Aspergillus terreus Gwq-48 with anti-influenza A viral (H1N1) activity.
Ocean University of China
22
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
Chinese Academy of Sciences
17
Enhanced anti-influenza agents conjugated with anti-inflammatory activity.
National Taiwan University
37
Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.
Chinese Academy of Sciences
11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
Chosun University
8
Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
Chulalongkorn University
7
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
National Taiwan University
29
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
Shandong University
9
Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata.
Chosun University
4
CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.
Daiichi Sankyo
10
New stilbenoid with inhibitory activity on viral neuraminidases from Erythrina addisoniae.
Chosun University
13
Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Simon Fraser University
15
C-Methylated Flavonoids from Cleistocalyx operculatus and Their Inhibitory Effects on Novel Influenza A (H1N1) Neuraminidase.
Chosun University
27
QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
Universidad De Buenos Aires
26
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
Peking Union Medical College
1
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.
University of California
35
Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
Shandong University
45
QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.
Lanzhou University
40
Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.
National Institute of Pharmaceutical Education and Research (NIPER)
25
Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
Shandong University
13
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
Shandong University
8
Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors.
Shenyang Pharmaceutical University
7
Peramivir conjugates as orally available agents against influenza H275Y mutant.
National Taiwan University
1
Synthesis and anti-influenza virus evaluation of triterpene-sialic acid conjugates.
Meiji Pharmaceutical University
24
Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
Konkuk University
8
Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses.
National Taiwan University
19
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.
Shandong University
28
Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
Shandong University
6
C-Methylated Flavonoid Glycosides from Pentarhizidium orientale Rhizomes and Their Inhibitory Effects on the H1N1 Influenza Virus.
Seoul National University
25
Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
Shanghai Institute of Technology
6
Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives.
Csiro Manufacturing
13
JAK inhibitors containing a 4-membered heterocyclic amide
Theravance Biopharma R&D Ip
370
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
Leo Pharma
89
Substituted spiropiperidinyl compounds useful as GPR120 agonists
Merck Sharp & Dohme
73
Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders
Bristol Myers Squibb
125
Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators
Janssen Pharmaceutica
22
Histone deacetylase inhibitors and compositions and methods of use thereof
Chdi Foundation
12
Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
Harbin Gloria Pharmaceuticals
12
Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Georg-August-University